U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07690228) titled 'A Phase 1 Study of GSM-779690T in Healthy Adult Participants' on July 02.
Brief Summary: A Phase 1, single-centre, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of a single and multiple dose regimens of GSM-779690T in healthy adults. This first-in-human study will evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of GSM-779690T.
Study Start Date: Aug. 15
Study Type: INTERVENTIONAL
Condition:
Healthy Adult Participants
Alzheimer Disease
Intervention:
DRUG: GSM-779690T
Opaque capsules for oral consumption...